Aprecia Pharmaceuticals
PrivateLast Round
Debt
Jul 5, 2016
Total Funding Raised
$65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aprecia Pharmaceuticals operates in Healthcare & Life Sciences and is based in Mason, Ohio. Its latest recorded funding round was a Debt round in July 2016.
Aprecia Pharmaceuticals is a pharmaceutical company that develops and manufactures orodispersible formulations of high-dose medications using its proprietary three-dimensional printing (3DP) ZipDose technology platform.
Sector
Healthcare & Life Sciences
Verticals
3D Printing, Biotechnology, Defense Tech, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aprecia Pharmaceuticals Comparables
Compare Aprecia Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laxxon Medical | 79% | |
| Triastek | 79% | |
| FabRx | 76% |
For institutional investors. Book with your work email.
Aprecia Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 5, 2016 | ||||
| Private Equity | Jan 27, 2016 | ||||
| VC Round | Nov 11, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aprecia Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| Deerfield Management | Private Equity |
| JW Asset Management | Private Equity |
| JW Asset Management | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 57% MoM.
- Aug 21, 2026
Monthly visitors grew 76% MoM, reaching 3.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 11, 2026
Aprecia Pharmaceuticals, LLC. launches its newest manufacturing technology platform, which enables real-time rapid release and tracks individual tablets to manufacturing-process data for agile pharmaceutical manufacturing.
For institutional investors. Book with your work email.
Aprecia Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aprecia Pharmaceuticals's valuation, stock price, and market status.
Is Aprecia Pharmaceuticals a public or private company?
Aprecia Pharmaceuticals is a private company.
What is the current stock price of Aprecia Pharmaceuticals?
Aprecia Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Aprecia Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aprecia Pharmaceuticals worth (valuation)?
Valuation information for Aprecia Pharmaceuticals is not publicly available.
Can I buy Aprecia Pharmaceuticals stock?
Aprecia Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aprecia Pharmaceuticals's last funding round?
Aprecia Pharmaceuticals's most recent funding round was Debt on July 5, 2016.
Who are the main investors in Aprecia Pharmaceuticals?
Key investors in Aprecia Pharmaceuticals include Hercules Capital, Deerfield Management.
Will Aprecia Pharmaceuticals IPO soon?
No public IPO plans have been announced for Aprecia Pharmaceuticals.
How can I track Aprecia Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Aprecia Pharmaceuticals's shares on secondary markets.